Xantho Biotechnology Co., Ltd.
PrivateCompany Overview
Xantho Biotechnology Co., Ltd. is a biotechnology company that develops botanical new drugs for the treatment of dermatological conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xantho Biotechnology Co., Ltd. Comparables
Compare Xantho Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alphyn Biologics, Inc. | 80% | |
| Santalis Pharmaceuticals | 79% | |
| HiST Pharma | 77% |
Xantho Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors increased 233% MoM.
Xantho Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Xantho Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Xantho Biotechnology Co., Ltd. a public or private company?
Xantho Biotechnology Co., Ltd. is a private company.
What is the current stock price of Xantho Biotechnology Co., Ltd.?
Xantho Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Xantho Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xantho Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Xantho Biotechnology Co., Ltd. is not publicly available.
Can I buy Xantho Biotechnology Co., Ltd. stock?
Xantho Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xantho Biotechnology Co., Ltd.'s last funding round?
Funding round information for Xantho Biotechnology Co., Ltd. is not publicly available.
Who are the main investors in Xantho Biotechnology Co., Ltd.?
Investor information for Xantho Biotechnology Co., Ltd. is not publicly disclosed.
Will Xantho Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Xantho Biotechnology Co., Ltd..
How can I track Xantho Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Xantho Biotechnology Co., Ltd.'s shares on secondary markets.